Skip to main content

Animations

MJFF Publications

4521 - 4530 of 6431 Results
Title
Year
  • Year
  • 2016
  • 2018
  • 2023
  • 2022
  • 2024
  • 2020
  • 2020
  • 2012
  • 2020
  • 2017
  • Summary Details
    OPEN
    Title: LRRK2 Regulates Voltage-Gated Calcium Channel Function
    Journal Name: Frontiers in Molecular Neuroscience
    Publisher: Frontiers Media SA
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.3389/fnmol.2016.00035
    Citation Count: 54
  • Summary Details
    OPEN
    Title: Alpha Synuclein Fibrils Contain Multiple Binding Sites for Small Molecules
    Journal Name: ACS Chemical Neuroscience
    Publisher: American Chemical Society (ACS)
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1021/acschemneuro.8b00177
    Citation Count: 71
  • Summary Details
    OPEN
    Title: American Football Play and Parkinson Disease Among Men
    Journal Name: JAMA Network Open
    Publisher: American Medical Association (AMA)
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1001/jamanetworkopen.2023.28644
    Citation Count: 17
  • Summary Details
    OPEN
    Title: Gender Differences in the Prevalence of Parkinson's Disease
    Journal Name: Movement Disorders Clinical Practice
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1002/mdc3.13584
    Citation Count: 48
  • Summary Details
    OPEN
    Title: Development of Pyridothiophene Compounds for PET Imaging of α‐Synuclein
    Journal Name: Chemistry – A European Journal
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1002/chem.202303921
    Citation Count: 7
  • Summary Details
    OPEN
    Title: LRRK2 inhibitors induce reversible changes in nonhuman primate lungs without measurable pulmonary deficits
    Journal Name: Science Translational Medicine
    Publisher: American Association for the Advancement of Science (AAAS)
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1126/scitranslmed.aav0820
    Citation Count: 114
  • Summary Details
    OPEN
    Title: A 12-month, dose-level blinded safety and efficacy study of levodopa inhalation powder (CVT-301, Inbrija) in patients with Parkinson's disease
    Journal Name: Parkinsonism & Related Disorders
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc-nd
    DOI - Digital Object Identifier: 10.1016/j.parkreldis.2020.10.029
    Citation Count: 19
  • Summary Details
    OPEN
    Title: The metabotropic glutamate receptor 8 agonist (S)-3,4-DCPG reverses motor deficits in prolonged but not acute models of Parkinson's disease
    Journal Name: Neuropharmacology
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1016/j.neuropharm.2012.03.029
    Citation Count: 30
  • Summary Details
    OPEN
    Title: A novel method for calculating beta band burst durations in Parkinson’s disease using a physiological baseline
    Journal Name: Journal of Neuroscience Methods
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc-nd
    DOI - Digital Object Identifier: 10.1016/j.jneumeth.2020.108811
    Citation Count: 30
  • Summary Details
    OPEN
    Title: TrkB neurotrophic activities are blocked by α-synuclein, triggering dopaminergic cell death in Parkinson’s disease
    Journal Name: Proceedings of the National Academy of Sciences
    Publisher: Proceedings of the National Academy of Sciences
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1073/pnas.1713969114
    Citation Count: 112
We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.